Bill
Bill > SF3786
MN SF3786
MN SF3786Epilepsy-related prescription drugs and medical supplies cost sharing limitation provision
summary
Introduced
02/23/2026
02/23/2026
In Committee
02/23/2026
02/23/2026
Crossed Over
Passed
Dead
Introduced Session
94th Legislature 2025-2026
Bill Summary
A bill for an act relating to health insurance; limiting cost-sharing for epilepsy-related prescription drugs and medical supplies; amending Minnesota Statutes 2024, section 62Q.481, subdivision 2.
AI Summary
This bill amends Minnesota Statutes 2024, section 62Q.481, subdivision 2, to include epilepsy as a chronic disease for the purposes of health insurance cost-sharing limitations. This means that cost-sharing, which refers to the patient's out-of-pocket expenses like co-payments and coinsurance, will now be limited for epilepsy-related prescription drugs and related medical supplies, such as syringes, insulin pens, test strips, and epinephrine auto-injectors, among others. The change is set to take effect on January 1, 2027, and will apply to health plans that are offered, issued, or renewed on or after that date, aiming to make essential epilepsy treatments more affordable for individuals with the condition.
Committee Categories
Business and Industry
Sponsors (2)
Last Action
Referred to Commerce and Consumer Protection (on 02/23/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.revisor.mn.gov/bills/94/2026/0/SF/3786/ |
| BillText | https://www.revisor.mn.gov/bills/94/2026/0/SF/3786/versions/0/pdf/ |
Loading...